Literature DB >> 9799081

Variant in sulfonylurea receptor-1 gene is associated with high insulin concentrations in non-diabetic Mexican Americans: SUR-1 gene variant and hyperinsulinemia.

D L Goksel1, K Fischbach, R Duggirala, B D Mitchell, L Aguilar-Bryan, J Blangero, M P Stern, P O'Connell.   

Abstract

The high-affinity sulfonylurea receptor (SUR1) gene regulates insulin secretion and may play a role in type 2 diabetes. A silent variant in exon 31 of SUR1 (AGG-->AGA) was detected by single-strand conformational polymorphism and genotypes were determined for 396 Mexican American subjects (289 non-diabetic). The normal and mutant alleles were designated G and A, respectively. Among non-diabetics, those with the AA genotype had higher fasting insulin values than those with the AG and GG genotypes (113.4 pmol/l for AA vs 82.8 pmol/l for AG/GG, P=0.043). Similar results were observed for 2-h insulin (849.6 pmol/l for AA vs 498.6 pmol/l for AG/GG, P=0.0003) and for the proinsulin to specific insulin ratio (0.068 for AA vs 0.056 for AG/GG, P=0.030). Specific insulin levels also differed significantly across the three genotypic classes (P=0.021). No differences in fasting glucose, body mass index, or waist circumference according to genotype were noted. Two-hour glucose was modestly higher in individuals with the AA genotype. Since we have previously reported linkage between SUR1 and hyperglycemia, the present association between a SUR1 variant and hyperinsulinemia in normal individuals from a high diabetes risk ethnic group raises the possibility of primary insulin hypersecretion as an antecedent of type 2 diabetes in at least some individuals from this population.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9799081     DOI: 10.1007/s004390050817

Source DB:  PubMed          Journal:  Hum Genet        ISSN: 0340-6717            Impact factor:   4.132


  8 in total

1.  A novel mechanism regulating insulin secretion involving Herpud1 in mice.

Authors:  N Wong; G Morahan; M Stathopoulos; J Proietto; S Andrikopoulos
Journal:  Diabetologia       Date:  2013-04-26       Impact factor: 10.122

2.  Gamete-competition models.

Authors:  J S Sinsheimer; J Blangero; K Lange
Journal:  Am J Hum Genet       Date:  2000-03       Impact factor: 11.025

Review 3.  Individualized therapy for type 2 diabetes: clinical implications of pharmacogenetic data.

Authors:  Gaia Chiara Mannino; Giorgio Sesti
Journal:  Mol Diagn Ther       Date:  2012-10       Impact factor: 4.074

4.  A serine/alanine polymorphism in the nucleotide-binding fold-2 of the sulphonylurea receptor-1 (S1369A) is associated with enhanced glucose-induced insulin secretion during pregnancy.

Authors:  W Krugluger; A Festa; N Shnawa; J Bucher; G Boltz-Nitulescu; G Schernthaner; P Hopmeier
Journal:  J Inherit Metab Dis       Date:  2000-11       Impact factor: 4.982

5.  Effects of St John's wort and CYP2C9 genotype on the pharmacokinetics and pharmacodynamics of gliclazide.

Authors:  H Xu; K M Williams; W S Liauw; M Murray; R O Day; A J McLachlan
Journal:  Br J Pharmacol       Date:  2008-01-21       Impact factor: 8.739

6.  Increased nicotinamide nucleotide transhydrogenase levels predispose to insulin hypersecretion in a mouse strain susceptible to diabetes.

Authors:  K Aston-Mourney; N Wong; M Kebede; S Zraika; L Balmer; J M McMahon; B C Fam; J Favaloro; J Proietto; G Morahan; S Andrikopoulos
Journal:  Diabetologia       Date:  2007-10-06       Impact factor: 10.122

7.  Too much of a good thing: why it is bad to stimulate the beta cell to secrete insulin.

Authors:  K Aston-Mourney; J Proietto; G Morahan; S Andrikopoulos
Journal:  Diabetologia       Date:  2008-02-02       Impact factor: 10.122

8.  Possible association between ABCC8 C49620T polymorphism and type 2 diabetes in a Nigerian population.

Authors:  Godwill Azeh Engwa; Friday Nweke Nwalo; Claribel Chidimma Chikezie; Christie Oby Onyia; Opeolu Oyejide Ojo; Wilfred Fon Mbacham; Benjamin Ewa Ubi
Journal:  BMC Med Genet       Date:  2018-05-12       Impact factor: 2.103

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.